4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-054900
Chief Financial Officer sold 10,000 shares at an average $177.49 ($1,774,927)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McAnear Justin J. · Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-01 | Exercise or conversion : show line 1 in the form | +10,000 | $5.04 | $50,400 | 49,100 | D |
| 2021-09-01 | Sale : show line 2 in the form | −374 | $174.87 | $65,401 | 48,726 | D |
| 2021-09-01 | Sale : show line 3 in the form | −1,139 | $175.95 | $200,412 | 47,587 | D |
| 2021-09-01 | Sale : show line 4 in the form | −2,200 | $177.00 | $389,396 | 45,387 | D |
| 2021-09-01 | Sale : show line 5 in the form | −4,747 | $177.87 | $844,359 | 40,640 | D |
| 2021-09-01 | Sale : show line 6 in the form | −1,540 | $178.80 | $275,358 | 39,100 | D |
| Open-market sales · 10,000 sh · avg $177.49 · $1,774,927 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-09-01 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −10,000 | $5.04 | 2028-11-02 | 10,000 | 390,159 | D |
Loading xslF345X03/doc4.xml…